180 related articles for article (PubMed ID: 15007383)
1. Nore1 inhibits tumor cell growth independent of Ras or the MST1/2 kinases.
Aoyama Y; Avruch J; Zhang XF
Oncogene; 2004 Apr; 23(19):3426-33. PubMed ID: 15007383
[TBL] [Abstract][Full Text] [Related]
2. Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases.
Avruch J; Praskova M; Ortiz-Vega S; Liu M; Zhang XF
Methods Enzymol; 2006; 407():290-310. PubMed ID: 16757333
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras.
Praskova M; Khoklatchev A; Ortiz-Vega S; Avruch J
Biochem J; 2004 Jul; 381(Pt 2):453-62. PubMed ID: 15109305
[TBL] [Abstract][Full Text] [Related]
4. NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers.
Hesson L; Dallol A; Minna JD; Maher ER; Latif F
Oncogene; 2003 Feb; 22(6):947-54. PubMed ID: 12584574
[TBL] [Abstract][Full Text] [Related]
5. RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1.
Tommasi S; Dammann R; Jin SG; Zhang XF; Avruch J; Pfeifer GP
Oncogene; 2002 Apr; 21(17):2713-20. PubMed ID: 11965544
[TBL] [Abstract][Full Text] [Related]
6. NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.
Macheiner D; Gauglhofer C; Rodgarkia-Dara C; Grusch M; Brachner A; Bichler C; Kandioler D; Sutterlüty H; Mikulits W; Schulte-Hermann R; Grasl-Kraupp B
Cancer Res; 2009 Jan; 69(1):235-42. PubMed ID: 19118008
[TBL] [Abstract][Full Text] [Related]
7. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1.
Ortiz-Vega S; Khokhlatchev A; Nedwidek M; Zhang XF; Dammann R; Pfeifer GP; Avruch J
Oncogene; 2002 Feb; 21(9):1381-90. PubMed ID: 11857081
[TBL] [Abstract][Full Text] [Related]
8. Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways.
Ikeda M; Hirabayashi S; Fujiwara N; Mori H; Kawata A; Iida J; Bao Y; Sato Y; Iida T; Sugimura H; Hata Y
Exp Cell Res; 2007 Apr; 313(7):1484-95. PubMed ID: 17367779
[TBL] [Abstract][Full Text] [Related]
9. NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma.
Macheiner D; Heller G; Kappel S; Bichler C; Stättner S; Ziegler B; Kandioler D; Wrba F; Schulte-Hermann R; Zöchbauer-Müller S; Grasl-Kraupp B
J Hepatol; 2006 Jul; 45(1):81-9. PubMed ID: 16516329
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma.
Chow LS; Lo KW; Kwong J; Wong AY; Huang DP
Oncol Rep; 2004 Oct; 12(4):781-7. PubMed ID: 15375500
[TBL] [Abstract][Full Text] [Related]
11. The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma.
Geli J; Kiss N; Lanner F; Foukakis T; Natalishvili N; Larsson O; Kogner P; Höög A; Clark GJ; Ekström TJ; Bäckdahl M; Farnebo F; Larsson C
Endocr Relat Cancer; 2007 Mar; 14(1):125-34. PubMed ID: 17395981
[TBL] [Abstract][Full Text] [Related]
12. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS
BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel Ras-regulated proapoptotic pathway.
Khokhlatchev A; Rabizadeh S; Xavier R; Nedwidek M; Chen T; Zhang XF; Seed B; Avruch J
Curr Biol; 2002 Feb; 12(4):253-65. PubMed ID: 11864565
[TBL] [Abstract][Full Text] [Related]
14. Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
Seidel C; Schagdarsurengin U; Blümke K; Würl P; Pfeifer GP; Hauptmann S; Taubert H; Dammann R
Mol Carcinog; 2007 Oct; 46(10):865-71. PubMed ID: 17538946
[TBL] [Abstract][Full Text] [Related]
15. RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family.
Eckfeld K; Hesson L; Vos MD; Bieche I; Latif F; Clark GJ
Cancer Res; 2004 Dec; 64(23):8688-93. PubMed ID: 15574778
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors.
Lee CK; Lee JH; Lee MG; Jeong SI; Ha TK; Kang MJ; Ryu BK; Hwangbo Y; Shim JJ; Jang JY; Lee KY; Kim HJ; Chi SG
BMC Cancer; 2010 Oct; 10():577. PubMed ID: 20969767
[TBL] [Abstract][Full Text] [Related]
17. The growth and tumor suppressor NORE1A is a cytoskeletal protein that suppresses growth by inhibition of the ERK pathway.
Moshnikova A; Frye J; Shay JW; Minna JD; Khokhlatchev AV
J Biol Chem; 2006 Mar; 281(12):8143-52. PubMed ID: 16421102
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene.
Li J; Wang F; Protopopov A; Malyukova A; Kashuba V; Minna JD; Lerman MI; Klein G; Zabarovsky E
Oncogene; 2004 Aug; 23(35):5941-9. PubMed ID: 15208682
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of suppressive role of RASSF1A gene at 3p21.3 in lung cancer cell line A549].
Zhang S; Shao K; Zhang CY; Zhou F; Wang W; Xiong MH; He J
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):908-11. PubMed ID: 16029530
[TBL] [Abstract][Full Text] [Related]
20. Kinetic characterization of apoptotic Ras signaling through Nore1-MST1 complex formation.
Koturenkiene A; Makbul C; Herrmann C; Constantinescu-Aruxandei D
Biol Chem; 2017 May; 398(5-6):701-707. PubMed ID: 28141542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
